» Articles » PMID: 33786373

Blood Pressure Treatment in Kidney Transplant Recipients-Can We Improve?

Overview
Publisher Wolters Kluwer
Specialty General Surgery
Date 2021 Mar 31
PMID 33786373
Authors
Affiliations
Soon will be listed here.
Abstract

Methods: In conjunction with the 2018 annual data reporting, additional questions were added for recipients with BP >130/80 mm Hg (treating physician´s target BP for each patient, reasons for not achieving target, method of measurement).

Results: Annual forms were received from 98% (3407 of 3486) of KTx recipients, with 1787 (52%) reporting a BP >130/80 mm Hg ("above-target" group). These recipients were older, mostly male, with higher body mass index and serum creatinine levels ( < 0.05) compared with patients with controlled hypertension ("on-target" group). Valid survey answers were available for 84% of the "above-target" group (Surv) with no significant demographic differences versus nonresponders (Surv). Among Surv, 32% were under antihypertensive dose titration, whereas dose-limiting side effects were reported in 7%. Target BP was confirmed to 130/80 mm Hg for 60% of Surv. In recipients for whom the treating physician set target BP >130/80 mm Hg, 51% did not reach these individual targets. The number of antihypertensive drugs was significantly higher in the "above-target" group versus "on-target" group (mean 2.1 ± 1.2 versus 1.8 ± 1.3) and 36% versus 25% used ≥3 antihypertensive drugs ( < 0.05). Automatic attended BP measurement was utilized by 51%.

Conclusions: In KTx recipients, a higher BP target achievement seems possible, potentially in the range of 75%-80%.

References
1.
Calhoun D, Jones D, Textor S, Goff D, Murphy T, Toto R . Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008; 117(25):e510-26. DOI: 10.1161/CIRCULATIONAHA.108.189141. View

2.
Opelz G, Wujciak T, Ritz E . Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int. 1998; 53(1):217-22. DOI: 10.1046/j.1523-1755.1998.00744.x. View

3.
Stoumpos S, Jardine A, Mark P . Cardiovascular morbidity and mortality after kidney transplantation. Transpl Int. 2014; 28(1):10-21. DOI: 10.1111/tri.12413. View

4.
Ho P, Bryson C, Rumsfeld J . Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009; 119(23):3028-35. DOI: 10.1161/CIRCULATIONAHA.108.768986. View

5.
Oniscu G, Brown H, Forsythe J . How great is the survival advantage of transplantation over dialysis in elderly patients?. Nephrol Dial Transplant. 2004; 19(4):945-51. DOI: 10.1093/ndt/gfh022. View